EMERALD BIOVENTURES, LLC reported 1 transaction at GALERA THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 5/29/2026ACC: 0001123292-26-000772
10% Owner
Since Apr 2026
+20.79M
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
20.81M acquired · 20.81K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
+20.81M
Price / share
—
Trade value
—
% of position
51.8%
5/15/2026
40.22M→61.03M
Total
Net shares
+20.81M
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/15/2026 | C · Conversion | +20.81M | — | — | 51.8% | 40.22M | 61.03M |
| Total | +20.81M | $0.00 | ||||||
Derivative Transactions1
Series B Preferred Stock
Direct
Converts to
Common Stock
20.81M shares
Shares
−20.81K
Strike price
Held after
0.00
Exercisable
—
5/15/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series B Preferred Stock Direct | Common Stock20.81M shares | 5/15/2026 | C · Conversion | −20.81K | — | 0.00 |